Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colonic Neoplasms × encorafenib × Clear all

Phase

Status

Active not recruiting 5 Recruiting 2 Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 12 Colorectal Neoplasms 9 Neoplasm Metastasis 4 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Solid Tumors Harboring a BRAF V600 Mutation 1 Skin Neoplasms 1 Skin Diseases 1 Recurrence 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Lung Neoplasms 1 Gastrointestinal Neoplasms 1 Digestive System Neoplasms 1 Colonic Neoplasms 1 Brain Neoplasms 1 Advanced BRAF Mutant Cancers 1

Interventions

Fluorouracil 127 Leucovorin 119 Oxaliplatin 100 Irinotecan 89 Bevacizumab 55 Cetuximab 44 Capecitabine 40 Folfox protocol 29 Panitumumab 22 Colonoscopy 17 Chemotherapy, Adjuvant 16 Floxuridine 15 Early Intervention, Educational 14 Erlotinib Hydrochloride 12 Surveys and Questionnaires 11 IFL protocol 11 Immunohistochemistry 10 Gemcitabine 10 Counseling 10 Psychiatric Rehabilitation 9 Celecoxib 9 Methods 8 Magnetic Resonance Spectroscopy 8 Gene Expression Profiling 8 Exercise 8 Dexamethasone 8 Cyclophosphamide 8 sargramostim 7 Sorafenib 7 Radiotherapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05510895 2025-10-01

NeoBRAF

AIO-Studien-gGmbH

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡